Palette Life Sciences

Stockholm, Sweden Founded: 2016 • Age: 10 yrs Acquired By Teleflex Medical
Generic finished formulations are manufactured for urology and colorectal conditions.
Request Access

About Palette Life Sciences

Palette Life Sciences is a company based in Stockholm (Sweden) founded in 2016 was acquired by Teleflex Medical in July 2023.. Palette Life Sciences has raised $30 million across 3 funding rounds from investors including SVB, Teleflex Medical and Orbimed. Palette Life Sciences offers products and services including Barrigel and Deflux.

  • Headquarter Stockholm, Sweden
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Palette Life Sciences, Inc
Operational Areas
Healthcare → Pharmaceuticals & Therapeutics
Healthcare → Medical Devices & Diagnostics
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Total Equity Funding
    $30 M (USD)

    in 3 rounds

  • Latest Funding Round
  • Investors
    SVB

    & 3 more

  • Employee Count
    Employee Count
  • Acquired by
    Teleflex Medical

    (Jul 26, 2023)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Palette Life Sciences

Palette Life Sciences offers a comprehensive portfolio of products and services, including Barrigel and Deflux. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Barrigel is utilized in medical applications as a trademark that was acquired by Teleflex

Deflux is employed in urological treatments and is recognized as a trademark under Teleflex

People of Palette Life Sciences
Headcount 50-200
Employee Profiles 8
Board Members and Advisors 6
Employee Profiles
People
Per Langoe
CEO
People
Ole Steven Mikkelsen
Chief Operating Officer
People
Richard Low Jr.
VP of Marketing
People
Domenique Severo
Barrigel Procedural Specialist, Northeast

Unlock access to complete

Board Members and Advisors
people
Gun Nilsson
Director
people
Paul De Potocki
Director
people
David R. Amerson
Chairman
people
Newton Aguiar
Director

Unlock access to complete

Funding Insights of Palette Life Sciences

Palette Life Sciences has successfully raised a total of $30M across 3 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding
  • Total Rounds 3
  • Last Round
  • First Round

    (21 Oct 2021)

  • Investors Count 3
Date Amount Transaction Name Valuation Lead Investors Investors
Mar, 2023 Amount Debt – Conventional - Palette Life Sciences Valuation

investors

Oct, 2021 Amount Debt – Conventional - Palette Life Sciences Valuation

investors

SVB
Oct, 2021 Amount Series B - Palette Life Sciences Valuation Schörling
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Palette Life Sciences

Palette Life Sciences has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include SVB, Teleflex Medical and Orbimed. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
Investments are made by OrbiMed in global healthcare innovations across biopharmaceuticals and related fields.
Founded Year Domain Location
Banking services are provided to innovative companies, investors, and individuals.
Founded Year Domain Location
Business consulting services are provided by Schörling in Sweden.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Palette Life Sciences

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - Palette Life Sciences

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Palette Life Sciences Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Palette Life Sciences

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Palette Life Sciences

Frequently Asked Questions about Palette Life Sciences

When was Palette Life Sciences founded?

Palette Life Sciences was founded in 2016 and raised its 1st funding round 5 years after it was founded.

Where is Palette Life Sciences located?

Palette Life Sciences is headquartered in Stockholm, Sweden.

Is Palette Life Sciences a funded company?

Palette Life Sciences is a funded company, having raised a total of $30M across 3 funding rounds to date. The company's 1st funding round was a Series B of $30M, raised on Oct 21, 2021.

What does Palette Life Sciences do?

Palette Life Sciences was founded in 2016 and is based in Stockholm, Sweden. Operations center on the production of generic finished formulations within the pharmaceutical sector. Key products include Deflux for vesicoureteral reflux, Solesta for fecal incontinence, Barrigel for rectal wall protection during radiotherapy, and Lidbree. Focus areas encompass urology, urogynecology disorders, colorectal conditions, and interventional oncology procedures.

What products or services does Palette Life Sciences offer?

Palette Life Sciences offers Barrigel and Deflux.

Who are Palette Life Sciences's investors?

Palette Life Sciences has 4 investors. Key investors include SVB, Teleflex Medical, Orbimed, and Schörling.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available